4
Changes in Ownership
Transcode Therapeutics, Inc. Filed Acc 0001104659-22-100931
Chief Executive Officer bought 20,000 shares at $1.15 ($23,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dudley Robert Michael Chief Executive Officer | 2022-09-14 | Purchase | +20,000 | $1.15 | $23,000 | 893,114 | D |
| Open-market purchases · 20,000 sh · avg $1.15 · $23,000 | |||||||
Loading xslF345X03/tm2226100-1_4seq1.xml…